Brief Intervention for Chronic Pain and History of Stressful Experiences

Brigham and Women's Hospital50 enrolled

Overview

The goal of this study is to understand whether a brief, three session program can be helpful in reducing symptoms related to both chronic pain and stressful experiences/trauma.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Chronic Pain Trauma Adverse Childhood Experiences

Interventions

Trauma Focused Emotional Awareness and Expression Therapy (EAET)BEHAVIORAL

The intervention is three-session program which includes pain neuroscience education, education on the relationship between trauma and chronic pain, and skills training to reduce pain- and stress-related symptoms.

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presence of a chronic pain condition (pain for at least 3 months or more) * History of psychosocial trauma or stressful experience (Adverse Childhood Events questionnaire \[ACEs\] score of ≥ 3 OR Trauma History Questionnaire Score \[THQ\] of ≥ 2) * English fluency * Access to a smartphone, laptop, or computer * Able to participate in the intervention via a virtual platform Exclusion Criteria: * Unable to participate in 3 weekly sessions * Unable to complete study procedures due to the presence of delirium, dementia, psychosis, or other cognitive impairment

Locations (1)

Brigham and Women's Hospital

Chestnut Hill, Massachusetts, United States

Outcomes

Primary Outcomes

Feasibility of Recruitment

Feasibility of recruitment: Rate of ≥70% of the patients who are identified as eligible for the study will agree to participate and enroll.

Time frame: At screening

Treatment Completion

Rate of ≥70% of participants who start the intervention will complete at least 2 of the 3 sessions.

Time frame: From enrollment to end of treatment at 4 weeks

Feasibility of Data Collection

Rate of ≥70% of participants will complete the survey at end of treatment and at 1-month follow-up.

Time frame: At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Treatment Credibility

Rate of ≥70% of participants will report average credibility and expectancy scores greater than the scale's midpoint.

Time frame: At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Treatment Helpfulness

Rate of ≥70% participants will report average treatment helpfulness scores greater than the scale's midpoint.

Time frame: At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Secondary Outcomes

Pain Interference

Pain interference Sub-scale of the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29). Range 4-20; higher scores indicate worse pain interference.

Time frame: At end of treatment at (~4 weeks post-enrollment), and at 1-month follow-up (~8 weeks post-enrollment)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.